RE:RE:RE:RE:RE:I like it ! did you always know you wanted to be a shill or was it just an opportunity you came across?
did they find you on another bullboard and see your good work or do they hire from the unemployment line?
mercedesman wrote: BayStreetWild wrote: MM October 06, 2022
mercedesman wrote: Agreed Rev
IMO this fall will not be a repeat of last fall despite some recent BS(W) posts.
1) Enrollment ramp-up at hand (flu season back with a vengence in 2022 - see southern hemisphere coming to North, 17-25 Trial sites, ICU more clear after CV lull period, etc).
2) Likely news on the Dialco side (this financing only deals with PMX). I don't see back to back market financings. I think there is someone out there that sees the next FDA approved machine on the horizon and wants to get in on the ground floor. That should somewhat wake up the market on hidden value/ under priced assets.
3) Different buyers of this financing. Instead of a detached US institution looking to cash in on warrants, this is "strategic partners", insiders and larger shareholders (stronger hands)
4) Spectral has appreciated throughout the market malaise (from .16 to 40's and 50's)...so now there is less need for tax loss selling. Plus short term possibilities on Dialco would make it a dangerous short...so would ramped up enrollment (agreed we still need evidence first - but JK needs to regain his credibility)
MM
Revten wrote: Looks like we will be Buying More Shares at a Bargain Basment Price thanks to the Weak Hands who clearly are not seeing what Is Really Going On Here!
Wake Up People! This is not an If FDA Approval....It's just a matter Of When it is FDA Approved!
The insiders are only taking advantage of TIME!
it's All About Timing....and we will all look back at .40 and say...WAS I ASLEEP??
This is a Much Better and more realistic type of Financing!
Clearly the Trial is going MUCH MUCH Better Than Expected and a Strategic Partner? Wake Up!
Still Very REVED Up and will be ONLY on the Buy Side until we are Trading 5 to 10 Million Shares A Day! That is when I will be able to Liquidate such a Large Position!
So as not to bore the board, I will respond to just one of your posts.
My post held up exceedingly well....
Here's my update
Indeed this past fall was not a repeat of last fall (2021) despite some recent BS(W) posts. 1) Enrollment ramp-up at hand (flu season back with in 2022 - I expect inprovements this winter/spring. check 2) Future monetization of Dialco pending (just a carve out of assets from Spectral so far). I don't see back to back market financings. I think there is someone out there that will see the next FDA approved machine on the horizon, and who will want to get in on the ground floor. That should somewhat wake up the market on hidden value/ under priced assets. check 3) Different buyers of this financing. Instead of a detached US institution looking to cash in on warrants, this is "strategic partners", insiders and larger shareholders (stronger hands) - check 4) Spectral has appreciated throughout the market malaise (from .16 to 30's)...and in late 2022 there was no need for tax loss selling. Plus monetization possibilities on Dialco would make it a dangerous short...so would ramped up enrollment (agreed we still need evidence first - but JK needs to regain his credibility) - check